4 days agoSparingVision’s lead asset SPVN06 clears IND application in the US for retinitis pigmentosa
Jun 84BIO Capital Portfolio Company Code Biotherapeutics Closes an Oversubscribed $75 Million Series A
Jun 64BIO Capital co-leads $30 million (¥3.86 Billion) oversubscribed Series B financing in LUCA Science
Apr 27Ray Therapeutics Receives $4M in Funding from the California Institute for Regenerative Medicine
